- Zeroing in on canine atopic dermatitis
- What makes dogs itch?
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
- Apoquel vs. Atopica: a comparison of two medications to control atopic dermatitis in dogs
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of 117 dogs with atopic dermatitis. Part 1: control of pruritus (itch).
Learn more about RESPIT
Subscribe to the SkinVet e-Newsletter!
Tag Archives: dermatology
By Jon Plant, DVM, DACVD Apoquel® (oclacitinib) is the new Zoetis drug for the treatment of atopic and allergic dermatitis in dogs at least 12 months of age. I’ve been prescribing Apoquel for almost 3 months now and I must … Continue reading
Jon D. Plant, DVM, Dipl. ACVD If you haven’t already, you will soon be hearing a lot about APOQUEL® for the management of allergic dermatitis and atopic dermatitis in dogs at least 12 months of age. APOQUEL® is a new … Continue reading
Allergen-specific immunotherapy (ASIT) is frequently used to manage canine atopic dermatitis (AD). The selection of allergens for ASIT is based on intradermal testing (IDT), allergen-specific immunoglobulin E (IgE) assays, patient history, and aerobiological data. In theory, an optimal allergenic extract … Continue reading
RESPIT, regionally-specific immunotherapy, is the practical allergy immunotherapy alternative that you can prescribe for atopic dermatitis in dogs and cats without allergy testing. I recently conducted a survey of all 160 veterinarians who had prescribed RESPIT Injectable prior to September … Continue reading
By Jon D. Plant, DVM, Dipl. ACVD Long before I developed regionally-specific immunotherapy (RESPIT), I was interested in studying the efficacy of allergen-specific immunotherapy (ASIT) in dogs. Why? The only placebo controlled study on ASIT, although a noble effort, had … Continue reading
by Jon Plant, DVM, DACVD Two routes of administration may be used for allergen immunotherapy: subcutaneous injection or oromucosal / sublingual. The subcutaneous route has been in use in humans and animals for more than 50 years. After an initial … Continue reading
With the rapid emergence of methicillin-resistant strains of Stapylococcus pseudintermedius (MRSP), the potential for nosocomial infections should be addressed by every veterinary hospital with a formal, written infection control program. Most of the control measures for MR staphylococci are applicable … Continue reading